Pivotal role for decorin in angiogenesis

Matrix Biology

Volumn 43, Issue , 2015, Pages 15-26

  Järveläinen, Hannu ^a,b   Sainio, Annele ^a   Wight, Thomas N ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Decorin; Extracellular matrix; Mechanism; Proteoglycan; Therapy

Indexed keywords

ANGIOPOIETIN; CELL SURFACE RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 6; CONNECTIVE TISSUE GROWTH FACTOR; DECORIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; DCN PROTEIN, HUMAN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; AUTOPHAGY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FOREIGN BODY REACTION; HUMAN; INTRACELLULAR SIGNALING; MACROMOLECULE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCAR FORMATION; ANIMAL; INFLAMMATION; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); TUMOR MICROENVIRONMENT;

ANGIOGENESIS INHIBITORS; ANIMALS; CELLULAR MICROENVIRONMENT; DECORIN; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84930181202     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.01.023     Document Type: Review

References (171)

1. Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992, 267:10931-10934.
2. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
3. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395.
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
5. van der Veer W.M., Niessen F.B., Ferreira J.A., Zwiers P.J., de Jong E.H., Middelkoop E., et al. Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans. Wound Repair Regen 2011, 19:292-301.
6. Ingber D.E., Folkman J. How does extracellular matrix control capillary morphogenesis?. Cell 1989, 58:803-805.
7. Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007, 26:58-68.
8. Neve A., Cantatore F.P., Maruotti N., Corrado A., Ribatti D. Extracellular Matrix Modulates Angiogenesis in physiological and pathological conditions. Biomed Res Int 2014, 2014:756078.
9. Belotti D., Foglieni C., Resovi A., Giavazzi R., Taraboletti G. Targeting angiogenesis with compounds from the extracellular matrix. Int J Biochem Cell Biol 2011, 43:1674-1685.
10. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012, 196:395-406.
11. Park K.P., Du P., Subbiah R., Park J.H. Vascular morphogenesis of human umbilical vein endothelial cells on cell-derived macromolecular matrix microenvironment. Tissue Eng Part A 2014, 20:2365-2377.
12. Vernon R.B., Sage E.H. Between molecules and morphology. Extracellular matrix and creation of vascular form. Am J Pathol 1995, 147:873-883.
13. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003, 161:1163-1177.
14. Obika M., Vernon R.B., Gooden M.D., Braun K.R., Chan C.K., Wight T.N. ADAMTS-4 and biglycan are expressed at high levels and co-localize to podosomes during endothelial cell tubulogenesis in vitro. J Histochem Cytochem 2014, 62:34-49.
15. Seano G., Chiaverina G., Gagliardi P.A., di Blasio L., Puliafito A., Bouvard C., et al. Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis. Nat Cell Biol 2014, 16:931-941.
16. Sweeney S.M., DiLullo G., Slater S.J., Martinez J., Iozzo R.V., Lauer-Fields J.L., et al. Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly. J Biol Chem 2003, 278:30516-30524.
17. Twardowski T., Fertala A., Orgel J.P., San Antonio J.D. Type I collagen and collagen mimetics as angiogenesis promoting superpolymers. Curr Pharm Des 2007, 13:3608-3621.
18. Bahramsoltani M., Harms T., Drewes B., Plendl J. Searching for markers to identify angiogenic endothelial cells: a proteomic approach. Clin Hemorheol Microcirc 2013, 55:255-269.
19. Mammoto T., Jiang A., Jiang E., Panigrahy D., Kieran M.W., Mammoto A. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am J Pathol 2013, 183:1293-1305.
20. Nicosia R.F., Bonanno E., Smith M. Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol 1993, 154:654-661.
21. Yi M., Ruoslahti E. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci U S A 2001, 98:620-624.
22. Li R., Luo M., Ren M., Chen N., Xia J., Deng X., et al. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis. J Vasc Res 2014, 51:110-117.
23. Simon-Assmann P., Orend G., Mammadova-Bach E., Spenle C., Lefebvre O. Role of laminins in physiological and pathological angiogenesis. Int J Dev Biol 2011, 55:455-465.
24. Lawler P.R., Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med 2012, 2:a006627.
25. Jendraschak E., Sage E.H. Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Semin Cancer Biol 1996, 7:139-146.
26. Aviezer D., Hecht D., Safran M., Eisinger M., David G., Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994, 79:1005-1013.
27. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001, 107:R9-R14.
28. De Rossi G., Whiteford J.R. Syndecans in angiogenesis and endothelial cell biology. Biochem Soc Trans 2014, 42:1643-1646.
29. Järveläinen H.T., Iruela-Arispe M.L., Kinsella M.G., Sandell L.J., Sage E.H., Wight T.N. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 1992, 203:395-401.
30. Schönherr E., O'Connell B.C., Schittny J., Robenek H., Fastermann D., Fisher L.W., et al. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 1999, 78:44-55.
31. Berendsen A.D., Pinnow E.L., Maeda A., Brown A.C., McCartney-Francis N., Kram V., et al. Biglycan modulates angiogenesis and bone formation during fracture healing. Matrix Biol 2014, 35:223-231.
32. Zheng P.S., Wen J., Ang L.C., Sheng W., Viloria-Petit A., Wang Y., et al. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 2004, 18:754-756.
33. Fu Y., Nagy J.A., Brown L.F., Shih S.C., Johnson P.Y., Chan C.K., et al. Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis. J Histochem Cytochem 2011, 59:463-473.
34. Jian J., Zheng Z., Zhang K., Rackohn T.M., Hsu C., Levin A., et al. Fibromodulin promoted in vitro and in vivo angiogenesis. Biochem Biophys Res Commun 2013, 436:530-535.
35. Albig A.R., Roy T.G., Becenti D.J., Schiemann W.P. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis 2007, 10:197-216.
36. West D.C., Kumar S. Hyaluronan and angiogenesis. Ciba Found Symp 1989, 143:187-201.
37. Savani R.C., Cao G., Pooler P.M., Zaman A., Zhou Z., DeLisser H.M. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001, 276:36770-36778.
38. Ingber D. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem 1991, 47:236-241.
39. Maquart F.X., Simeon A., Pasco S., Monboisse J.C. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J Soc Biol 1999, 193:423-428.
40. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 2000, 156:1489-1498.
41. Ricard-Blum S., Salza R. Matricryptins and matrikines: biologically active fragments of the extracellular matrix. Exp Dermatol 2014, 23:457-463.
42. Marneros A.G., Olsen B.R. Physiological role of collagen XVIII and endostatin. FASEB J 2005, 19:716-728.
43. Kamphaus G.D., Colorado P.C., Panka D.J., Hopfer H., Ramchandran R., Torre A., et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000, 275:1209-1215.
44. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002, 295:140-143.
45. Mongiat M., Sweeney S.M., San Antonio J.D., Fu J., Iozzo R.V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003, 278:4238-4249.
46. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
47. Senger D.R., Davis G.E. Angiogenesis. Cold Spring Harb Perspect Biol 2011, 3:a005090.
48. Kinsella M.G., Wight T.N. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J Cell Biol 1986, 102:679-687.
49. Järveläinen H.T., Kinsella M.G., Wight T.N., Sandell L.J. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 1991, 266:23274-23281.
50. Salisbury B.G., Wagner W.D. Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta. J Biol Chem 1981, 256:8050-8057.
51. Oldberg Å., Antonsson P., Lindblom K., Heinegard D. A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J 1989, 8:2601-2604.
52. Adany R., Heimer R., Caterson B., Sorrell J.M., Iozzo R.V. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J Biol Chem 1990, 265:11389-11396.
53. Iozzo R.V., Murdoch A.D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996, 10:598-614.
54. Nastase M.V., Iozzo R.V., Schaefer L. Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim Biophys Acta 1840, 2014:2460-2470.
55. Pogany G., Vogel K.G. The interaction of decorin core protein fragments with type I collagen. Biochem Biophys Res Commun 1992, 189:165-172.
56. Orgel J.P., Eid A., Antipova O., Bella J., Scott J.E. Decorin core protein (decoron) shape complements collagen fibril surface structure and mediates its binding. PLoS One 2009, 4:e7028.
57. Kalamajski S., Oldberg Å. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol 2010, 29:248-253.
58. Reese S.P., Underwood C.J., Weiss J.A. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. Matrix Biol 2013, 32:414-423.
59. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743.
60. Brandan E., Gutierrez J. Role of skeletal muscle proteoglycans during myogenesis. Matrix Biol 2013, 32:289-297.
61. Wu Z., Horgan C.E., Carr O., Owens R.T., Iozzo R.V., Lechner B.E. Biglycan and decorin differentially regulate signaling in the fetal membranes. Matrix Biol 2014, 35:266-275.
62. Dunkman A.A., Buckley M.R., Mienaltowski M.J., Adams S.M., Thomas S.J., Kumar A., et al. The injury response of aged tendons in the absence of biglycan and decorin. Matrix Biol 2014, 35:232-238.
63. Sofeu Feugaing D.D., Gotte M., Viola M. More than matrix: the multifaceted role of decorin in cancer. Eur J Cell Biol 2013, 92:1-11.
64. Horvath Z., Kovalszky I., Fullar A., Kiss K., Schaff Z., Iozzo R.V., et al. Decorin deficiency promotes hepatic carcinogenesis. Matrix Biol 2014, 35:194-205.
65. Bianco P., Fisher L.W., Young M.F., Termine J.D., Robey P.G. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990, 38:1549-1563.
66. Krusius T., Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A 1986, 83:7683-7687.
67. Mann D.M., Yamaguchi Y., Bourdon M.A., Ruoslahti E. Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis. J Biol Chem 1990, 265:5317-5323.
68. Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997, 32:141-174.
69. Weber I.T., Harrison R.W., Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 1996, 271:31767-31770.
70. Bella J., Hindle K.L., McEwan P.A., Lovell S.C. The leucine-rich repeat structure. Cell Mol Life Sci 2008, 65:2307-2333.
71. Goldoni S., Owens R.T., McQuillan D.J., Shriver Z., Sasisekharan R., Birk D.E., et al. Biologically active decorin is a monomer in solution. J Biol Chem 2004, 279:6606-6612.
72. Seidler D.G., Goldoni S., Agnew C., Cardi C., Thakur M.L., Owens R.T., et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 2006, 281:26408-26418.
73. Seidler D.G., Dreier R. Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function?. IUBMB Life 2008, 60:729-733.
74. Seidler D.G. The galactosaminoglycan-containing decorin and its impact on diseases. Curr Opin Struct Biol 2012, 22:578-582.
75. Goldoni S., Seidler D.G., Heath J., Fassan M., Baffa R., Thakur M.L., et al. An antimetastatic role for decorin in breast cancer. Am J Pathol 2008, 173:844-855.
76. Hu Y., Sun H., Owens R.T., Wu J., Chen Y.Q., Berquin I.M., et al. Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia 2009, 11:1042-1053.
77. Bartolini B., Thelin M.A., Svensson L., Ghiselli G., van Kuppevelt T.H., Malmström A., et al. Iduronic acid in chondroitin/dermatan sulfate affects directional migration of aortic smooth muscle cells. PLoS One 2013, 8:e66704.
78. Stock C., Jungmann O., Seidler D.G. Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification. J Cell Physiol 2011, 226:2641-2650.
79. Nomura Y. Structural change in decorin with skin aging. Connect Tissue Res 2006, 47:249-255.
80. Kirkpatrick N.D., Andreou S., Hoying J.B., Utzinger U. Live imaging of collagen remodeling during angiogenesis. Am J Physiol Heart Circ Physiol 2007, 292:H3198-H3206.
81. Gutierrez P., O'Brien K.D., Ferguson M., Nikkari S.T., Alpers C.E., Wight T.N. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc Pathol 1997, 6:271-278.
82. Nelimarkka L., Salminen H., Kuopio T., Nikkari S., Ekfors T., Laine J., et al. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 2001, 158:345-353.
83. Bosse A., Schwarz K., Vollmer E., Kresse H. Divergent and co-localization of the two small proteoglycans decorin and proteoglycan-100 in human skeletal tissues and tumors. J Histochem Cytochem 1993, 41:13-19.
84. Burke A.P., Järveläinen H., Kolodgie F.D., Goel A., Wight T.N., Virmani R. Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans. Mod Pathol 2004, 17:482-488.
85. Reich-Schupke S., Mumme A., Altmeyer P., Stuecker M. Decorin expression with stump recurrence and neovascularization after varicose vein surgery - a pilot study. Dermatol Surg 2011, 37:480-485.
86. Schönherr E., Sunderkötter C., Schaefer L., Thanos S., Grassel S., Oldberg Å., et al. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 2004, 41:499-508.
87. Nayak S., Goel M.M., Bhatia V., Chandra S., Makker A., Kumar S., et al. Molecular and phenotypic expression of decorin as modulator of angiogenesis in human potentially malignant oral lesions and oral squamous cell carcinomas. Indian J Pathol Microbiol 2013, 56:204-210.
88. Chui A., Murthi P., Gunatillake T., Brennecke S.P., Ignjatovic V., Monagle P.T., et al. Altered decorin leads to disrupted endothelial cell function: a possible mechanism in the pathogenesis of fetal growth restriction?. Placenta 2014, 35:596-605.
89. Davies Cde L., Melder R.J., Munn L.L., Mouta-Carreira C., Jain R.K., Boucher Y. Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. Microvasc Res 2001, 62:26-42.
90. Grant D.S., Yenisey C., Rose R.W., Tootell M., Santra M., Iozzo R.V. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002, 21:4765-4777.
91. Salomäki H.H., Sainio A.O., Söderström M., Pakkanen S., Laine J., Jarvelainen H.T. Differential expression of decorin by human malignant and benign vascular tumors. J Histochem Cytochem 2008, 56:639-646.
92. Järveläinen H., Puolakkainen P., Pakkanen S., Brown E.L., Hook M., Iozzo R.V., et al. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen 2006, 14:443-452.
93. Sulochana K.N., Fan H., Jois S., Subramanian V., Sun F., Kini R.M., et al. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem 2005, 280:27935-27948.
94. Mohan R.R., Tovey J.C., Sharma A., Schultz G.S., Cowden J.W., Tandon A. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo. PLoS One 2011, 6:e26432.
95. Rada J.A., Cornuet P.K., Hassell J.R. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res 1993, 56:635-648.
96. Kinsella M.G., Fischer J.W., Mason D.P., Wight T.N. Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem 2000, 275:13924-13932.
97. Järveläinen H., Vernon R.B., Gooden M.D., Francki A., Lara S., Johnson P.Y., et al. Overexpression of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro. Arterioscler Thromb Vasc Biol 2004, 24:67-72.
98. Rühland C., Schönherr E., Robenek H., Hansen U., Iozzo R.V., Bruckner P., et al. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J 2007, 274:4246-4255.
99. Fiedler L.R., Schönherr E., Waddington R., Niland S., Seidler D.G., Aeschlimann D., et al. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem 2008, 283:17406-17415.
100. Sztrolovics R., White R.J., Poole A.R., Mort J.S., Roughley P.J. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J 1999, 339(Pt 3):571-577.
101. Pins G.D., Christiansen D.L., Patel R., Silver F.H. Self-assembly of collagen fibers. Influence of fibrillar alignment and decorin on mechanical properties. Biophys J 1997, 73:2164-2172.
102. Krishnan L., Hoying J.B., Nguyen H., Song H., Weiss J.A. Interaction of angiogenic microvessels with the extracellular matrix. Am J Physiol Heart Circ Physiol 2007, 293:H3650-H3658.
103. Huttenlocher A., Werb Z., Tremble P., Huhtala P., Rosenberg L., Damsky C.H. Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. Matrix Biol 1996, 15:239-250.
104. Schönherr E., Schaefer L., O'Connell B.C., Kresse H. Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression. J Cell Physiol 2001, 187:37-47.
105. Mazor R., Alsaigh T., Shaked H., Altshuler A.E., Pocock E.S., Kistler E.B., et al. Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells. J Biol Chem 2013, 288:598-607.
106. Al Haj Zen A., Lafont A., Durand E., Brasselet C., Lemarchand P., Godeau G., et al. Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 2003, 22:251-258.
107. Neill T., Painter H., Buraschi S., Owens R.T., Lisanti M.P., Schaefer L., et al. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 2012, 287:5492-5506.
108. Valente P., Fassina G., Melchiori A., Masiello L., Cilli M., Vacca A., et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 1998, 75:246-253.
109. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003, 9:407-415.
110. Rojiani M.V., Alidina J., Esposito N., Rojiani A.M. Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp Pathol 2010, 3:775-781.
111. Fiedler L.R., Eble J.A. Decorin regulates endothelial cell-matrix interactions during angiogenesis. Cell Adh Migr 2009, 3:3-6.
112. Jungmann O., Nikolovska K., Stock C., Schulz J.N., Eckes B., Riethmuller C., et al. The dermatan sulfate proteoglycan decorin modulates alpha2beta1 integrin and the vimentin intermediate filament system during collagen synthesis. PLoS One 2012, 7:e50809.
113. D'Antoni M.L., Risse P.A., Ferraro P., Martin J.G., Ludwig M.S. Effects of decorin and biglycan on human airway smooth muscle cell adhesion. Matrix Biol 2012, 31:101-112.
114. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994, 264:569-571.
115. Weis S.M., Cheresh D.A. AlphaV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med 2011, 1:a006478.
116. Moscatello D.K., Santra M., Mann D.M., McQuillan D.J., Wong A.J., Iozzo R.V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998, 101:406-412.
117. Iozzo R.V., Moscatello D.K., McQuillan D.J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999, 274:4489-4492.
118. Goldoni S., Humphries A., Nyström A., Sattar S., Owens R.T., McQuillan D.J., et al. Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 2009, 185:743-754.
119. Schönherr E., Sunderkötter C., Iozzo R.V., Schaefer L. Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 2005, 280:15767-15772.
120. Iozzo R.V., Buraschi S., Genua M., Xu S.Q., Solomides C.C., Peiper S.C., et al. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem 2011, 286:34712-34721.
121. Morrione A., Neill T., Iozzo R.V. Dichotomy of decorin activity on the insulin-like growth factor-I system. FEBS J 2013, 280:2138-2149.
122. Khan G.A., Girish G.V., Lala N., Di Guglielmo G.M., Lala P.K. Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol Endocrinol 2011, 25:1431-1443.
123. Baghy K., Horvath Z., Regos E., Kiss K., Schaff Z., Iozzo R.V., et al. Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. FEBS J 2013, 280:2150-2164.
124. Reed C.C., Gauldie J., Iozzo R.V. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 2002, 21:3688-3695.
125. Dil N., Banerjee A.G. Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro. Head Neck Oncol 2012, 4:3284-4284.
126. Santra M., Santra S., Zhang J., Chopp M. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3. J Neurochem 2008, 105:324-337.
127. Rosenbloom J., Castro S.V., Jimenez S.A. Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 2010, 152:159-166.
128. Kuzuya M., Kinsella J.L. Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors. Exp Cell Res 1994, 215:310-318.
129. Kuzuya M., Kinsella J.L. Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel): involvement of transforming growth factor beta 1. J Cell Physiol 1994, 161:267-276.
130. Mandriota S.J., Menoud P.A., Pepper M.S. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 1996, 271:11500-11505.
131. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002, 21:1743-1753.
132. Ferrari G., Cook B.D., Terushkin V., Pintucci G., Mignatti P. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol 2009, 219:449-458.
133. Mahmoud M., Upton P.D., Arthur H.M. Angiogenesis regulation by TGFbeta signalling: clues from an inherited vascular disease. Biochem Soc Trans 2011, 39:1659-1666.
134. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284.
135. Border W.A., Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992, 90:1-7.
136. Hildebrand A., Romaris M., Rasmussen L.M., Heinegård D., Twardzik D.R., Border W.A., et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994, 302(Pt 2):527-534.
137. Schönherr E., Broszat M., Brandan E., Bruckner P., Kresse H. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 1998, 355:241-248.
138. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D., Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997, 322:809-814.
139. Boivin W.A., Shackleford M., Vanden Hoek A., Zhao H., Hackett T.L., Knight D.A., et al. Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-beta1. PLoS One 2012, 7:e33163.
140. Isaka Y., Brees D.K., Ikegaya K., Kaneda Y., Imai E., Noble N.A., et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996, 2:418-423.
141. Stander M., Naumann U., Dumitrescu L., Heneka M., Loschmann P., Gulbins E., et al. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther 1998, 5:1187-1194.
142. Nili N., Cheema A.N., Giordano F.J., Barolet A.W., Babaei S., Hickey R., et al. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol 2003, 163:869-878.
143. Scott R.A., Panitch A. Decorin mimic regulates platelet-derived growth factor and interferon-gamma stimulation of vascular smooth muscle cells. Biomacromolecules 2014, 15:2090-2103.
144. Penc S.F., Pomahac B., Winkler T., Dorschner R.A., Eriksson E., Herndon M., et al. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem 1998, 273:28116-28121.
145. Morcavallo A., Buraschi S., Xu S.Q., Belfiore A., Schaefer L., Iozzo R.V., et al. Decorin differentially modulates the activity of insulin receptor isoform A ligands. Matrix Biol 2014, 35:82-90.
146. Kaji T., Yamamoto C., Oh-i M., Nishida T., Takigawa M. Differential regulation of biglycan and decorin synthesis by connective tissue growth factor in cultured vascular endothelial cells. Biochem Biophys Res Commun 2004, 322:22-28.
147. Ward W.K., Li A.G., Siddiqui Y., Federiuk I.F., Wang X.J. Increased expression of Interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants. J Biomater Sci Polym Ed 2008, 19:1065-1072.
148. Vial C., Gutierrez J., Santander C., Cabrera D., Brandan E. Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. J Biol Chem 2011, 286:24242-24252.
149. Kristensen I.B., Pedersen L., Ro T.B., Christensen J.H., Lyng M.B., Rasmussen L.M., et al. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration. Eur J Haematol 2013, 91:196-200.
150. Moreth K., Iozzo R.V., Schaefer L. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 2012, 11:2084-2091.
151. Bruno A., Pagani A., Pulze L., Albini A., Dallaglio K., Noonan D.M., et al. Orchestration of angiogenesis by immune cells. Front Oncol 2014, 4:131.
152. Landskron G., De la Fuente M., Thuwajit P., Thuwajit C., Hermoso M.A. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014, 2014:149185.
153. Niu J., Azfer A., Zhelyabovska O., Fatma S., Kolattukudy P.E. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 2008, 283:14542-14551.
154. Lindner D.J. Interferons as antiangiogenic agents. Curr Oncol Rep 2002, 4:510-514.
155. Bocian C., Urbanowitz A.K., Owens R.T., Iozzo R.V., Gotte M., Seidler D.G. Decorin potentiates interferon-gamma activity in a model of allergic inflammation. J Biol Chem 2013, 288:12699-12711.
156. Neill T., Schaefer L., Iozzo R.V. Instructive roles of extracellular matrix on autophagy. Am J Pathol 2014, 184:2146-2153.
157. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
158. Ramakrishnan S., Nguyen T.M., Subramanian I.V., Kelekar A. Autophagy and angiogenesis inhibition. Autophagy 2007, 3:512-515.
159. Buraschi S., Neill T., Goyal A., Poluzzi C., Smythies J., Owens R.T., et al. Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci U S A 2013, 110:E2582-E2591.
160. Goyal A., Neill T., Owens R.T., Schaefer L., Iozzo R.V. Reprint of: Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. Matrix Biol 2014, 35:42-50.
161. Neill T., Torres A., Buraschi S., Iozzo R.V. Decorin has an appetite for endothelial cell autophagy. Autophagy 2013, 9:1626-1628.
162. Boström P., Sainio A., Kakko T., Savontaus M., Söderström M., Järveläinen H. Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast. Histochem Cell Biol 2013, 139:161-171.
163. Hamid A.S., Li J., Wang Y., Wu X., Ali H.A., Du Z., et al. Recombinant human decorin upregulates p57KIP(2) expression in HepG2 hepatoma cell lines. Mol Med Rep 2013, 8:511-516.
164. Yu X., Zou Y., Li Q., Mao Y., Zhu H., Huang G., et al. Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro. Tumour Biol 2014, 35:3103-3112.
165. Dimmeler S., Zeiher A.M. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000, 87:434-439.
166. Neill T., Schaefer L., Iozzo R.V. Decorin: a guardian from the matrix. Am J Pathol 2012, 181:380-387.
167. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61.
168. Moserle L., Jimenez-Valerio G., Casanovas O. Antiangiogenic therapies: going beyond their limits. Cancer Dis 2014, 4:31-41.
169. Järvinen T.A., Ruoslahti E. Targeted antiscarring therapy for tissue injuries. Adv Wound Care (New Rochelle) 2013, 2:50-54.
170. Chaudhary K., Moore H., Tandon A., Gupta S., Khanna R., Mohan R.R. Nanotechnology and adeno-associated virus based decorin gene therapy ameliorates peritoneal fibrosis. Am J Physiol Renal Physiol 2014, 307:F777-F782.
171. Ma R., Chen J., Li Z., Tang J., Wang Y., Cai X. Decorin accelerates the liver regeneration after partial hepatectomy in fibrotic mice. Chin Med J (Engl) 2014, 127:2679-2685.